---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-036766"
form_type: "8-K"
ticker: "AMRN"
cik: "0000897448"
company_name: "AMARIN CORP PLCUK"
filed_at: "2023-08-02T23:59:59+00:00"
generated_at: "2026-06-12T15:59:13.906898+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Amarin Q2 revenue $80M (-15%); net loss narrows to $17.6M; lowers 2023 opex guidance

## Summary
- Total net revenue $80.2M (-15% YoY); net product revenue $65.2M (-31% YoY) due to generic competition.
- GAAP net loss $17.6M ($0.04 loss per share) vs $70.0M loss ($0.18 loss) in Q2 2022; non-GAAP adjusted net income $8.6M.
- Cash and investments $313M; generated positive cash flow of $9M during the quarter.
- Lowering 2023 operating expense guidance to $240-250M from $270-285M; cost reduction plan savings $40M over 12 months.
- Spain's drug pricing committee recommended national reimbursement of VAZKEPA; regulatory approvals in China and Saudi Arabia.

## SEC filing metadata
- accession: 0000950170-23-036766
- form_type: 8-K
- ticker: AMRN
- cik: 0000897448
- company_name: AMARIN CORP PLCUK
- filed_at: 2023-08-02T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/897448/000095017023036766/0000950170-23-036766-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/897448/000095017023036766/amrn-20230802.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-036766
- JSON: https://secwatch.observer/filing/0000950170-23-036766.json
- Plain text: https://secwatch.observer/filing/0000950170-23-036766.txt

## Key facts
- Earnings Releases
  AMARIN CORP PLCUK reported three months ended June 30, 2023 results: revenue Net product revenue for the three months ended June 30, 2023, was $65.2 million.
  - Period: three months ended June 30, 2023
  - Revenue: Net product revenue for the three months ended June 30, 2023, was $65.2 million
  - Result: reported results
  source text: Total net revenue for the three months ended June 30, 2023, was $80.2 million, compared to $94.4 million in the corresponding period of 2022, a decrease of 15%.
  evidence_url: https://www.sec.gov/Archives/edgar/data/897448/000095017023036766/0000950170-23-036766-index.htm
- Earnings Releases
  AMARIN CORP PLCUK reported three months ended June 30, 2023 results: revenue Net product revenue for the three months ended June 30, 2023, was $65.2 million.
  - Period: three months ended June 30, 2023
  - Revenue: Net product revenue for the three months ended June 30, 2023, was $65.2 million
  - Result: reported results
  source text: Net product revenue for the three months ended June 30, 2023, was $65.2 million, compared to $93.8 million in the corresponding period of 2022, a decrease of 31%.
  evidence_url: https://www.sec.gov/Archives/edgar/data/897448/000095017023036766/0000950170-23-036766-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.